Longeveron Discloses Nasdaq Non-Compliance Over Missing Audit Committee Financial Expert
Summary
Longeveron Inc. has disclosed that it is out of compliance with Nasdaq Listing Rule 5605(c)(2)(A) due to the resignation of its audit committee chair, who was also the financial expert. While the company has added an independent director to restore the committee to three members, it still lacks a qualified audit committee financial expert. This disclosure follows a recent PRE 14A filing where the company proposed a reverse stock split, indicating broader challenges with Nasdaq listing requirements. Failure to appoint a qualified financial expert within the 180-day cure period could lead to delisting proceedings, posing a significant risk to the company's public trading status and raising governance concerns. Investors should monitor the company's progress in addressing this compliance issue.
At the time of this announcement, LGVN was trading at $0.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.3M. The 52-week trading range was $0.48 to $1.92. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.